Insider · CIK 0001758428
Jake Singleton
Files at JYNT (JOINT Corp). First filing -, latest -.
Jake Singleton files SEC Form 4 as CFO at JYNT (JOINT Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jake Singleton has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 29, 2025 | JYNT JOINT Corp | 12,000 0.08% of outstanding | $128k | Aug 29, 2025 | $215k |
| Aug 25, 2025 | JYNT JOINT Corp | 20,000 0.13% of outstanding | $215k | Aug 22, 2025 | none |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | JYNT JOINT Corp | AGrant or award Common Stock | +15,936 | $0.00 | $0 | 69,224 | Mar 12, 2025 |
Questions about Jake Singleton
Answered from the filings on this page, as of the latest one.
Is Jake Singleton buying or selling?
Jake Singleton has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jake Singleton's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jake Singleton has 0.
Where does Jake Singleton file Form 4?
Jake Singleton has filed Form 4 at JYNT (JOINT Corp) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.